Related Experiment Video
Updated: Jun 25, 2026
Transcutaneous Microcirculatory Imaging in Preterm Neonates
Published on: December 31, 2015
Comprehensive evaluation of risk factors for intraventricular hemorrhage in preterm neonates: a systematic review and
Mobin Ghaderi1, Maryam Afraie2, Bita Pourahmad3
1Student Research Committee, Kurdistan University of Medical Sciences, Sanandaj, Iran.
Insights
Identifying risk factors for intraventricular hemorrhage (IVH) in preterm neonates is crucial. Male gender, low birth weight, asphyxia, and respiratory distress syndrome increase IVH risk, while antenatal steroids may reduce it.
Area of Science:
- Neonatalogy
- Perinatal Medicine
- Pediatric Neurology
Background:
- Intraventricular hemorrhage (IVH) is a significant cause of mortality and morbidity in preterm neonates.
- Early identification of risk factors is essential for improving outcomes and guiding management strategies.
Purpose of the Study:
- To systematically review and analyze clinical conditions and therapeutic interventions associated with IVH risk in preterm neonates.
- To provide evidence-based insights for prevention and management strategies.
Main Methods:
- A systematic review and meta-analysis of 30 studies were conducted.
- Risk factors were categorized into clinical conditions and therapeutic interventions.
- Pooled relative risks (RR) and heterogeneity assessments were used for data analysis.
Main Results:
- Significant clinical risk factors for IVH include male gender (RR: 1.15), low birth weight <1000g (RR: 1.94), Apgar ≤7 (RR: 2.14), asphyxia (RR: 1.70), and thrombocytopenia (RR: 1.34).
- Neonatal conditions like respiratory distress syndrome (RDS) and hyaline membrane disease (HMD) also increased IVH risk.
- Therapeutic interventions associated with increased risk include mechanical ventilation (RR: 3.27) and surfactant administration (RR: 2.32), while antenatal steroids showed a reduced risk (RR: 0.79).
Conclusions:
- Multiple clinical factors and therapeutic interventions are significantly associated with IVH risk in neonates.
- Early identification and management of high-risk neonates are critical.
- Further research is needed to refine IVH prevention strategies.
Objective:
Intraventricular hemorrhage (IVH) is a major cause of morbidity and mortality among preterm neonates, making early identification of risk factors critical to improving outcomes. Understanding both clinical conditions and therapeutic interventions associated with IVH can guide prevention and management strategies.
Methods:
A systematic review and meta-analysis were conducted, incorporating 30 studies that investigated various risk factors for IVH. The studies were categorized based on the clinical conditions and therapeutic interventions involved. The data were analyzed using pooled relative risks (RR) and heterogeneity assessments, including I2 values and P-values.
Results:
The analysis revealed several significant clinical risk factors for IVH. Male gender was associated with a 15% increased risk of IVH (pooled RR: 1.15, 95% CI 1.00-1.32), while low birth weight (< 1000g) was linked to a 94% increased risk (pooled RR: 1.94, 95% CI 1.38-2.73). Other significant factors included the presence of Apgar ≤ 5 or 7 (pooled RR: 2.14, 95% CI 1.69-2.72), asphyxia (pooled RR: 1.70, 95% CI 1.26-2.28), and thrombocytopenia (pooled RR: 1.34, 95% CI 1.10-1.62). Neonatal conditions such as respiratory distress syndrome (RDS) and hyaline membrane disease (HMD) were also found to increase IVH risk significantly. In terms of therapeutic interventions, antenatal steroids were associated with a reduced risk of IVH (pooled RR: 0.79, 95% CI 0.70-0.89), while mechanical ventilation, the use of catecholamines, surfactant administration increased IVH risk significantly (pooled RR for mechanical ventilation: 3.27, 95% CI 2.77-3.86; pooled RR for surfactant: 2.32, 95% CI 1.61-3.35).
Conclusion:
Several clinical factors and therapeutic interventions are associated with the risk of IVH in neonates. These findings emphasize the importance of early identification and management of high-risk neonates, as well as the need for further research to refine prevention strategies.
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...